Analysis of Isoniazid, Streptomycin and Ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco

Journal of Infection in Developing Countries

Volumn 3, Issue 4, 2009, Pages 278-284

  Chaoui, Imane ^a   Sabouni, Radia ^b   Kourout, Moussa ^b   Jordaan, Annemie M ^c   Lahlou, Ouafae ^b   Elouad, Rajae ^b   Akrim, Mohammed ^b   Victor, Thomas C ^c   El Mzibri, Mohammed ^a  

^a CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^b INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Drug resistance; Ethambutol; Genotyping; Isoniazid; Mycobacterium tuberculosis; Streptomycin

Indexed keywords

BACTERIAL PROTEIN; ETHAMBUTOL; ISONIAZID; KATG PROTEIN; PROTEIN EMB; PROTEIN INHA; PROTEIN RPSL; PROTEIN RRS; STREPTOMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MALE; MOROCCO; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; SPUTUM ANALYSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; FEMALE; GENOTYPE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOROCCO; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; STREPTOMYCIN; TUBERCULOSIS; YOUNG ADULT;

EID: 67649476432     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.125     Document Type: Article

References (31)

1. Cummins SL (1949) Tuberculosis in history. Williams and Wilkins, Baltimore.
2. Bloom BR and Murray CJL (1992) Tuberculosis: commentary on a reemergent killer. Science 257: 1055-1064.
3. Raviglione MC, Snider DE, Kochi A (1995) Global epidemiology of tuberculosis: morbidity and mortality of a world epidemic. JAMA 237: 202-226.
4. Soini H, and Musser JM (2001) Molecular diagnosis of mycobacteria. Clinical Chemistry 47:809-814.
5. Ramaswamy S and Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update. Tuber Lung Dis 79: 3-29.
6. Slayden RA, Lee RE, Barry CE 3rd (2000) Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol 38: 514-25.
7. Isakova ZhT, Goncharova ZK, Iusupova EU, Tumashova AF, Kozhomkulov MD, Kozhomkulov DK, Chubakov TCh, Alisherov ASh, Aldashev AA (2007) Analysis of mutations of multidrug-resistant Mycobacterium tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic Probl Tuberk Bolezn Legk. 4: 17-21.
8. Wu XQ, Lu Y, Zhang JX, Liang JQ, Li HM, Zhang GY, Lü CH, Ding BC (2006) Detection of the mutations in katG 315 and inhA -15 of Mycobacterium tuberculosis strains isolated from Chinese patients. Chin Med J 119: 230-3.
9. Springer B, Kidan YG, Prammananan T, Ellrott K, Böttger EC, Sander P (2001) Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob Agents Chemother 45: 2877-84.
10. Huang HN, Han JX, Wang JH, Song CZ, Liang H and Zhang (2003) rpsL gene analysis associated with Streptomycin resistance in Mycobacterium tuberculosis. Yi Chuan Xue Bao 30: 376-81.
11. Heifets LB, Iseman MD, Lindholm-levy PJ (1986) Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob agents chemother 30: 927-932.
12. Deng L, Mikusova K, Robuck KG, Scherman M, Brennan PJ, McNeil MR (1995) Recognition of multiple effects of ethambutol on metabolisms of mycobacterial cell envelope. Antimicrob Agents Chemother 39: 694-701.
13. Telenti A, Philip WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR (1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol Nature Med 3: 567-570.
14. Rattan L, Awdhesh K, Nishat A (1998) Multidrug-Resistant Mycobacterium tuberculosis: Molecular perspectives. Emerging Infectious Disease 4: 195-209.
15. Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, El Sahly H, Moghazeh SL, Kreiswirth BN, Musser JM (2000) Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44: 326-336.
16. Lee HY, Myoung H J, Bang HE, Bai GH, Kim SJ, Kim JD, Cho SN (2002) Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. Yonsei Med J 43: 59-64.
17. Ozturk CE, Sanic A, Kaya D, Ceyhan I (2005) Molecular analysis of Isoniazid, Rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Jpn J Infect Dis 58: 309-312.
18. Soualhine H, Ibrahimy S, Bennani A, Benlemlih M, Benslimane A (1998) Molecular mechanism of Rifampicin resistance in Mycobacterium tuberculosis. Clinical Mycobacteriology, ed. Casal m. and PROUS Science, Barcelone pp. 281-287.
19. Canetti G (1965) Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 92:687-70.
20. Victor TC, Jordaan AM, van Rie A, van der Spuy GD, Richardson M, van Helden PD, Warren R (1999) Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridisation strategy. Tuber Lung Dis 79: 343-8.
21. Victor TC, Warren R, Butt JL, Jordaan AM, Felix JV, Venter A, Sirgel FA, Schaaf HS, Donald PR, Richardson M, Cynamon MH, Van Helden PD (1997) Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J Med Microbio 46: 847-957.
22. Pretorius GS, Van Helden PD, Sirgel F, Eisenach KD, Victor TC (1995) Mutations in KatG sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob Agents Chemother 39: 2276-2281.
23. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, Simpson J, Gie RP, Enarson DA, Beyers N, van Helden PD, Victor TC (2001) Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39: 636-41.
24. Neralla S, Glassroth J (2003) Mycobacterium tuberculosis: the treatment of active disease. Semin Respir Infect 18: 292-306.
25. Johnson R, Jordaan AM, Warren R, Bosman M, Young D, Nagy JN, Wain JR, Van Helden PD, Victor TC (2008) Drug susceptibility testing using molecular techniques can enhance diagnosis in a community with a high tuberculosis incidence. J infect developing countries 2: 40-45.
26. Dar L, Khan B, Boussaha A, Padhy AK (2003) Molecular detection of drug resistance in microbes by isotopic techniques: The IAEA experience. World J Nucl Med 2: 52-59.
27. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy G, Kewley C, Bosman M, van Helden PD, Warren R, Victor TC (2006) Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Disease 10: 68-73.
28. Sreevastan S, Stockbauer KE, Pan X, Kreisworth BM, Moghazeh SL, Jacobs WR Jr, Telenti A, Musser JM (1997) Ethambutol resistance in Mycobacterium tuberculosis. Critical role of emb mutations. Antimicrob Agents Chemother 41: 1677-81.
29. Victor TC, van Helden PD, Warren R (2002) Prediction of drug resistance in Mycobacterium tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life 53: 231-237.
30. Musser JM (1995) Antimicrobial agent resistance in Mycobacteria: Molecular genetic insights. Clin Microbiol Rev 8: 496-514.
31. Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkami SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM (2004) Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Methods 57: 323-35.